SCHEMBL14808249

SCHEMBL14808249

Cc1ccc(C(=O)NC(=S)Nc2cccc([N+](=O)[O-])c2F)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.62
▸ L3MBTL1 Q9Y468 5/20 0.62
▸ RAB9A P51151 5/20 0.62
▸ NPC1 O15118 3/20 0.62
▸ ALDH1A1 P00352 12/20 0.58
▸ LMNA P02545 5/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ GAA P10253 2/20 0.58
▸ TP53 P04637 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ ALOX12 P18054 5/20 0.56
▸ KMT2A Q03164 6/20 0.55
▸ MEN1 O00255 5/20 0.55
▸ POLB P06746 2/20 0.52
▸ CRHBP P24387 2/20 0.52
▸ CRHR2 Q13324 2/20 0.52
▸ MAPK1 P28482 4/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4251730 0.77 MAPT (1.00) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL17897743 0.77 AKT1 (0.64) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL14807614 0.76 POLB (0.62) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL5713599 0.76 MAPT (0.73) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL2342297 0.76 NPC1 (0.77) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL28437427 0.75 PDPK1 (0.55) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL14096476 0.74 RAB9A (1.00) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL5647147 0.74 PKM (0.55) MAPTL3MBTL1RAB9ANPC1ALDH1A1
SCHEMBL14808169 0.74 MAPT (0.80) MAPTRAB9ANPC1ALDH1A1LMNA
SCHEMBL11162721 0.73 MAPT (0.81) MAPTL3MBTL1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150011528-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUHAN CORPORATION (KR) 2015-01-08 — — US disclosed
EP-2758384-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Yuhan Corporation (KR) 2014-07-30 — — EP disclosed
WO-2013043001-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME YUHAN CORPORATION (KR) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011528-A1 PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME ILK, PKMYT1, PLAUR MAPT 813/4885L3MBTL1 1631/4885RAB9A 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback